Oxycodone 40 mg Extended Release Tablets for Chronic Pain

Oxycodone 40 mg Extended Release Tablets are designed for effective, long-acting relief of moderate to severe pain that requires continuous, around-the-clock opioid treatment in analgesics category. Manufactured with advanced controlled-release technology, these tablets enable steady delivery of oxycodone over 12 hours, supporting sustained pain control with fewer doses.

Product Overview

• Active Ingredient: Oxycodone hydrochloride 40 mg per tablet
• Dosage Form: Round, biconvex, film-coated oral tablets with clear imprint for strength identification
• Release Profile: Extended-release matrix system engineered for gradual oxycodone release over 12 hours
• Packaging: Supplied in blister packs or bottles, ensuring product stability and security during storage and transport
• Compliance: Manufactured under stringent cGMP and international pharmacopeial standards

Indications

Oxycodone 40 mg extended release tablets are indicated for:

• Management of moderate to severe chronic pain where opioid therapy is appropriate
• Patients requiring continuous opioid administration beyond immediate-release formulations
• Situations where alternative pain treatments are inadequate or not tolerated

Key Features and Benefits

• Prolonged Analgesia: Maintains effective plasma concentration of oxycodone for up to 12 hours, reducing the need for frequent dosing and improving patient convenience.
• Consistent Pain Control: Minimizes breakthrough pain episodes by providing steady-state medication release.
• Patient-Friendly Formulation: Round, easy-to-swallow tablets designed with a controlled-release matrix to reduce peak plasma fluctuations.
• Safety Measures: Tablets possess a gel-forming property when exposed to liquid, deterring misuse and abuse by making crushing or dissolving difficult.
• Manufactured Quality: Produced in compliance with cGMP and ISO guidelines, ensuring batch-to-batch consistency, purity, and potency.

Dosage and Administration

• Prescribing oxycodone 40 mg extended release tablets must be individualized, starting with the lowest effective dose and titrating according to patient response and tolerance.
• Usually taken orally every 12 hours with water, consistent timing is important to maintain stable blood levels.
• Tablets must be swallowed whole; cutting, crushing, or chewing can disrupt the extended-release mechanism and increase risk of adverse effects.
• Regular monitoring for effectiveness, tolerance, and potential side effects is essential throughout therapy.

Safety Information

Contraindications:

• Hypersensitivity to oxycodone or any tablet components
• Significant respiratory depression or severe asthma
• Paralytic ileus or gastrointestinal obstruction
• Acute or severe bronchial asthma in an unmonitored setting

Warnings and Precautions:

• Risk of respiratory depression, especially in opioid-naïve patients or with dose escalation
• Careful use advised in elderly, debilitated, or patients with hepatic/renal impairment
• QT interval prolongation potential requires monitoring in susceptible individuals
• Avoid concomitant use with CNS depressants or alcohol to reduce additive sedation risks
• Caution to prevent misuse, abuse, and addiction

Common Adverse Effects:

• Drowsiness, dizziness, constipation, nausea, vomiting, sweating, and headache
• Less frequent but serious: respiratory depression, hypotension, cardiac arrhythmias

Drug Interactions:

• Enhanced sedation with benzodiazepines, alcohol, and other CNS depressants
• Metabolic interactions with CYP3A4 inhibitors or inducers can alter oxycodone plasma levels

Quality Assurance

• Rigorous quality control testing for potency, uniformity, dissolution, and purity
• Manufactured in accredited facilities adhering to international pharmaceutical quality standards
• Supported by comprehensive regulatory documentation and product traceability

Why Choose Oxycodone 40 mg Extended Release Tablets?

• Provides a reliable, long-acting opioid option to manage persistent moderate to severe pain
• Ease of use with twice-daily dosing improves patient compliance
• Controlled-release design reduces fluctuations and enhances safety
• Manufactured with abuse-deterrent formulation technology to help mitigate misuse
• Suitable for integration into chronic pain management protocols under strict medical supervision

For more information on product specifications, dosage adjustments, or ordering, please contact our clinical support team.

This product is intended for prescription use only. Treatment with oxycodone requires ongoing clinical monitoring by experienced healthcare professionals.